Epicrispr Biotechnologies

Epicrispr Biotechnologies

Epicrispr Biotechnologies

  • Epicrispr Biotechnologies just raised $90M (Series C) on Aug 10

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

2020Active51South San Francisco, United States
Rate

About

Epicrispr Biotechnologies is a clinical-stage biotechnology company pioneering gene-modulating therapies. They are focused on developing a new class of programmable epigenetic medicines designed to durably regulate gene expression without permanently altering the underlying DNA sequence. Their lead program, EPI-321, is in clinical trials for Facioscapulohumeral Muscular Dystrophy (FSHD).

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to Epicrispr Biotechnologies?

People comparing tools land here. Get listed beside these.

Copy Epicrispr Biotechnologies's SEO strategy

How often they publish, which searches their posts chase and their newest posts. Then outrank them.

All funding rounds

Key facts

Website
epicrispr.com
Headquarters
South San Francisco, United States
Founded
2020
Founder
Lei Stanley Qi
Employees
51
Total funding
$90M (Series C)
Business model
B2B

Funding rounds

Funding rounds raised by Epicrispr Biotechnologies
DateRoundAmountLead investors
10 Aug 2026Series C$90M

Tech stack

Detected on epicrispr.com, last scanned 13 Nov 2026.

Frontend
jQuery, Tailwind CSS, Bootstrap
Analytics
Google Analytics 4
SEO
Yoast SEO
CMS / Builders
WordPress
CDN
Cloudflare
Email provider
Google Workspace
Email marketing
Mailchimp

Benchmarking

See how your site ranks against 16,849 startups

Epicrispr Biotechnologies sits in the 48th percentile for Domain Rating. Check where yours lands, free.

Epicrispr Biotechnologies has a Domain Rating of 39, the 48th percentile of 16,849 startups we track.

Scores

Measured, not editorial

39

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Below median

Check yours
25

Measured by StartupHub.aiEffective DR

Our own read on real cross-surface visibility rather than raw backlink authority. A site can carry a high Domain Rating and still be invisible where people actually look, which is what this measures.

Bottom 25%

Check yours
39

Measured by StartupHub.aiAgent Readiness

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Below median

Scan yours
60

Measured by Google PageSpeedSite Speed

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Below median

PageSpeed
71

Measured by StartupHub.aiData Trust

Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.

Above median

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Agent Readiness

Can AI agents use your site?

Epicrispr Biotechnologies scores 39. Check yours free in a few seconds, or let Max Agent rerun it daily.

Run it daily with Max Agent
Median 41Across 23,755 scanned sites

Get notified when Epicrispr Biotechnologies changes

Used Epicrispr Biotechnologies? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

How people find Epicrispr Biotechnologies on Google

Searches that showed this page, last 28 days

Track your searches
  • epic bio$$$1 seen
  • epicrispr$$$1 seen
  • epicrispr biotechnologies$$$1 seen

$$$ high buyer intent (pricing, reviews, alternatives), $$ brand searches, $ research. Read from the wording, not ad prices.

Frequently asked

Is Epicrispr Biotechnologies growing?

Yes, fast. Our data shows it raised $90M in a Series C in August 2026.

Are there companies like Epicrispr Biotechnologies?

Yes. We list 6 companies like Epicrispr Biotechnologies, including Moderna, Degron Therapeutics and Pixelgen Technologies. Epicrispr Biotechnologies has raised more than 4 of the 6 with funding on record.

Is Epicrispr Biotechnologies trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Epicrispr Biotechnologies is 71 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Epicrispr Biotechnologies raised?

Epicrispr Biotechnologies has raised a total of $90M in funding. The most recent round on record is Series C.

How many employees does Epicrispr Biotechnologies have?

Epicrispr Biotechnologies has approximately 51 people on record.

SEC filings, insider activity, nonprofit links and pay benchmarks for Epicrispr Biotechnologies:

Company details: from public sources. Funding: 1 round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch Epicrispr Biotechnologies and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini